Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The need for evidence in genomic medicine

Michael P. Douglas and W. David Dotson, PhD
Conditions
April 21, 2012
Share
Tweet
Share

An IOM report makes recommendations that aim to ensure that progress in omics-based test development is grounded in sound scientific evidence and is reproducible, resulting in improved health care and continued public trust in research.  Another new IOM roundtable workshop report discussed the differences in evidence required for clinical use, regulatory oversight, guideline inclusion, coverage, and reimbursement of genomic diagnostic tests and focused on ways to clarify pathways for using such tests in clinical settings.

Recently, the NIH made a beta version of Genetic Test Registry (GTR) available online.  The GTR provides a central location for voluntary submission of genetic test information by developers. The GTR includes information on the test’s purpose, methodology, validity, evidence of the test’s usefulness, and laboratory contacts and credentials. The information provided is not verified by NIH, but assumed to be accurate by the submitting party. The GTR will not obviate the need for evidence-based evaluation of genetic tests and development of recommendations. However it is on track towards becoming useful to advance research and clinical practice.

So what are health care providers to do today when considering ordering a genomic test to diagnose, prevent or ameliorate a medical condition? Ultimately, providers and patients have to ask whether or not such a test can help in management of a health condition, and what is the balance of benefits and harms of such testing to the patient, the family, the community and the healthcare system.  Genomics and related fields (“Omics”) are rapidly emerging, resulting in many tests proposed to improve health. Since 2009, the CDC’s online GAPP Finder has catalogued more than 400 emerging tests, most of which are related to cancer. Unfortunately, beyond management of rare, single gene disorders, most new tests are not ready for use in clinical practice. The question is how do we know what is ready and what is not. After all, many people would like to have access to their personal genome information regardless of health related utility. This was reflected in the recent readers’ response to our blog on the topic of personal genomics.

In response to the need for evidence in genomic medicine, starting in 2005 the CDC Office of Public Health Genomics convened the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) working group, an independent, multidisciplinary and non-regulatory panel. The EGAPP working group develops and applies systematic methods to evaluate evidence for validity and utility of genomic applications used in specific clinical scenarios. To date, formal evaluation of 8 genomic test(s) have been conducted. One “positive” recommendation from the EGAPP working group is to offer genetic testing for Lynch syndrome to all individuals with newly diagnosed colorectal cancer (CRC) to reduce morbidity and mortality in relatives. Implementation of this recommendation today can save many lives.

More often, however, the EGAPP working group has found that there simply are not enough relevant, high quality studies available to support an evidence-based recommendation either for or against use of specific tests.  EGAPP recommendation statements identify specific gaps in knowledge to inform additional research. The EGAPP working group has been a pioneer in establishing evidentiary principles and published methods tailored to emerging genomic applications in medicine and public health. With so many new genomic tests becoming available and the need to develop novel evidence review processes, It is not surprising that only a few tests have been assessed and that the evidence-bar may seem too high.

As the number of genomic tests increases over the next few years, we need processes such as EGAPP, that provide an “honest broker” function in the evaluation of these technologies to inform providers, policy makers, patients and other stakeholders.  These processes involving professional organizations, researchers and consumers are crucial to balance the need for technological innovation with the need to show improved health outcomes, in order to realize the potential of genomic medicine in the 21st century.

Michael P. Douglas and W. David Dotson represent the Office of Public Health Genomics, Centers for Disease Control and Prevention.  They blog at the Genomics and Health Impact Blog.

Submit a guest post and be heard on social media’s leading physician voice.

Prev

What exactly is this thing we call healthcare?

April 21, 2012 Kevin 5
…
Next

What separates a developed and a developing country?

April 22, 2012 Kevin 4
…

Tagged as: Genetics

Post navigation

< Previous Post
What exactly is this thing we call healthcare?
Next Post >
What separates a developed and a developing country?

ADVERTISEMENT

More in Conditions

  • Addressing menstrual health inequities in adolescents

    Callia Georgoulis
  • Healing beyond the surface: Why proper chronic wound care matters

    Alvin May, MD
  • Why specialist pain clinics and addiction treatment services require strong primary care

    Olumuyiwa Bamgbade, MD
  • What a childhood stroke taught me about the future of neurosurgery and the promise of vagus nerve stimulation

    William J. Bannon IV
  • Facing terminal cancer as a doctor and mother

    Kelly Curtin-Hallinan, DO
  • Why doctors must stop ignoring unintentional weight loss in patients with obesity

    Samantha Malley, FNP-C
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Why clinical research is a powerful path for unmatched IMGs

      Dr. Khutaija Noor | Education
    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
    • How to advance workforce development through research mentorship and evidence-based management

      Olumuyiwa Bamgbade, MD | Physician
    • The truth about perfection and identity in health care

      Ryan Nadelson, MD | Physician
    • Civil discourse as a leadership competency: the case for curiosity in medicine

      All Levels Leadership | Physician
    • Healing beyond the surface: Why proper chronic wound care matters

      Alvin May, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Why clinical research is a powerful path for unmatched IMGs

      Dr. Khutaija Noor | Education
    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
    • How to advance workforce development through research mentorship and evidence-based management

      Olumuyiwa Bamgbade, MD | Physician
    • The truth about perfection and identity in health care

      Ryan Nadelson, MD | Physician
    • Civil discourse as a leadership competency: the case for curiosity in medicine

      All Levels Leadership | Physician
    • Healing beyond the surface: Why proper chronic wound care matters

      Alvin May, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...